Anti-N-sulfated heparan sulfate PE

*Kure S, Yoshie O: A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG) : cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1. J Immunol. 1986 Dec 15;137 (12) :3900-8., URL: https://www.ncbi.nlm.nih.gov/pubmed/2431047, *van den Born J, Salmivirta K, Henttinen T, Ostman N, Ishimaru T, Miyaura S, Yoshida K, Salmivirta M: Novel heparan sulfate structures revealed by monoclonal antibodies. J Biol Chem. 2005 May 27;280 (21) :20516-23., URL: https://www.ncbi.nlm.nih.gov/pubmed/15778504, *Lipscombe RJ, Nakhoul AM, Sanderson CJ, Coombe DR: Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix. J Leukoc Biol. 1998 Mar;63 (3) :342-50., URL: https://pubmed.ncbi.nlm.nih.gov/9500522/, *Crim RL, Audet SA, Feldman SA, Mostowski HS, Beeler JA: Identification of linear heparin-binding peptides derived from human respiratory syncytial virus fusion glycoprotein that inhibit infectivity. J Virol. 2007 Jan;81 (1) :261-71. Epub 2006 Oct 18., URL: https://www.ncbi.nlm.nih.gov/pubmed/17050595, *Chung JS, Shiue LH, Duvic M, Pandya A, Cruz PD Jr, Ariizumi K: Sézary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surface. Blood. 2011 Mar 24;117 (12) :3382-90., URL: https://www.ncbi.nlm.nih.gov/pubmed/21252093, *Kure S, Yoshie O, Aso H: Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan. Jpn J Cancer Res. 1987 Nov;78 (11) :1238-45., URL: https://www.ncbi.nlm.nih.gov/pubmed/2961717, *Mii Y, Yamamoto T, Takada R, Mizumoto S, Matsuyama M, Yamada S, Takada S, Taira M: Roles of two types of heparan sulfate clusters in Wnt distribution and signaling in Xenopus. Nat Commun. 2017 Dec 7;8 (1) :1973., URL: https://pubmed.ncbi.nlm.nih.gov/29215008/